Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Appointed director
|
|
SANGAMO THERAPEUTICS, INC (SGMO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/28/2023 |
4
| BIOGEN INC. (10% Owner) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 6,000,000 shares
@ $0.5, valued at
$3M
|
|
| 08/15/2023 |
4
| Willoughby Scott B. (SVP, Gen. Counsel & Secretary) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 864 shares
@ $1.08, valued at
$933.1 |
|
| 06/05/2023 |
4
| Smith Karen L. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 06/05/2023 |
4
| PARKER H STEWART (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 06/05/2023 |
4
| Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 06/05/2023 |
4
| Markels John (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 06/05/2023 |
4
| Horn Margaret A (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 06/05/2023 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 06/05/2023 |
4
| Carey Robert (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 06/05/2023 |
4
| Beers Courtney (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 05/30/2023 |
4
| Willoughby Scott B. (SVP, Gen. Counsel & Secretary) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,328 shares
@ $1.33, valued at
$1.8k
|
|
| 05/30/2023 |
4
| Ramelmeier Rolf Andrew (EVP, Technical Operations) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,750 shares
@ $1.33, valued at
$2.3k
|
|
| 05/30/2023 |
4
| McClung David Mark (EVP, COO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,925 shares
@ $1.33, valued at
$2.6k
|
|
| 05/30/2023 |
4
| Dubois-Stringfellow Nathalie (SVP-Chief Development Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,462 shares
@ $1.33, valued at
$1.9k
|
|
| 05/30/2023 |
4
| Fontenot Jason D. (SVP, Chief Scientific Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,029 shares
@ $1.33, valued at
$1.4k
|
|
| 05/30/2023 |
4
| Duraibabu Prathyusha (SVP, CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,328 shares
@ $1.33, valued at
$1.8k
|
|
| 05/30/2023 |
4
| Macrae Sandy (President, CEO and Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 10,411 shares
@ $1.33, valued at
$13.8k
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2023 |
4
| Willoughby Scott B. (SVP, Gen. Counsel & Secretary) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 42,750 shares
@ $0
Paid exercise price by delivering 5,128 shares
@ $2.66, valued at
$13.6k
Granted 199,500 options to buy
@ $2.66, valued at
$530.7k
|
|
| 03/06/2023 |
4
| Ramelmeier Rolf Andrew (EVP, Technical Operations) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 45,000 shares
@ $0
Paid exercise price by delivering 15,618 shares
@ $2.66, valued at
$41.5k
Granted 210,000 options to buy
@ $2.66, valued at
$558.6k
|
|
| 03/06/2023 |
4
| McClung David Mark (EVP, COO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 56,250 shares
@ $0
Paid exercise price by delivering 9,745 shares
@ $2.66, valued at
$25.9k
Granted 262,500 options to buy
@ $2.66, valued at
$698.3k
|
|
| 03/06/2023 |
4
| Dubois-Stringfellow Nathalie (SVP-Chief Development Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 53,438 shares
@ $0
Paid exercise price by delivering 9,834 shares
@ $2.66, valued at
$26.2k
Granted 249,375 options to buy
@ $2.66, valued at
$663.3k
|
|
| 03/06/2023 |
4
| Fontenot Jason D. (SVP, Chief Scientific Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 42,750 shares
@ $0
Paid exercise price by delivering 6,559 shares
@ $2.66, valued at
$17.4k
Granted 199,500 options to buy
@ $2.66, valued at
$530.7k
|
|
| 03/06/2023 |
4
| Duraibabu Prathyusha (SVP, CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 53,438 shares
@ $0
Paid exercise price by delivering 7,030 shares
@ $2.66, valued at
$18.7k
Granted 249,375 options to buy
@ $2.66, valued at
$663.3k
|
|
| 03/06/2023 |
4
| Macrae Sandy (President, CEO and Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 157,300 shares
@ $0
Paid exercise price by delivering 54,767 shares
@ $2.66, valued at
$145.7k
Granted 734,050 options to buy
@ $2.66, valued at
$2M
|
|
| 02/06/2023 |
4/A
| Duraibabu Prathyusha (SVP, CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 864 shares
@ $3.76, valued at
$3.2k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Horn Margaret A (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 18,750 shares
@ $0
Granted 37,500 options to buy
@ $3.3, valued at
$123.8k
|
|
| 12/19/2022 |
3
| Horn Margaret A (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 12/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/19/2022 |
3
| Dubois-Stringfellow Nathalie (SVP-Chief Development Officer) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 08/31/2022 |
4
| BIOGEN INC. (10% Owner) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 400,000 shares
@ $5.3268, valued at
$2.1M
Sold 100,000 shares
@ $5.2652, valued at
$526.5k
|
|
| 08/16/2022 |
4
| Willoughby Scott B. (SVP, Gen. Counsel & Secretary) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 864 shares
@ $6.33, valued at
$5.5k
|
|
|
|
|